Nishimura GI - Search Results

1

Trypsinogen expression in colorectal cancers.

Oyama K, Ohta T, Nishimura GI, Elnemr A, Yasui T, Fujimura T, Fushida S, Kitagawa H, Kayahara M, Terada T, Miwa K. Oyama K, et al. Among authors: nishimura gi. Int J Mol Med. 2000 Nov;6(5):543-8. doi: 10.3892/ijmm.6.5.543. Int J Mol Med. 2000. PMID: 11029521

2

Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma.

Funaki H, Nishimura G, Harada S, Ninomiya I, Terada I, Fushida S, Tani T, Fujimura T, Kayahara M, Shimizu K, Ohta T, Miwa K. Funaki H, et al. Oncology. 2003;64(4):416-22. doi: 10.1159/000070301. Oncology. 2003. PMID: 12759540

3

Protease-activated receptor-2 expression and the role of trypsin in cell proliferation in human pancreatic cancers.

Ohta T, Shimizu K, Yi S, Takamura H, Amaya K, Kitagawa H, Kayahara M, Ninomiya I, Fushida S, Fujimura T, Nishimura G, Miwa K. Ohta T, et al. Int J Oncol. 2003 Jul;23(1):61-6. Int J Oncol. 2003. PMID: 12792776

4

Angiotensin converting enzyme-independent, local angiotensin II-generation in human pancreatic ductal cancer tissues.

Ohta T, Amaya K, Yi S, Kitagawa H, Kayahara M, Ninomiya I, Fushida S, Fujimura T, Nishimura G, Shimizu K, Miwa K. Ohta T, et al. Int J Oncol. 2003 Sep;23(3):593-8. Int J Oncol. 2003. PMID: 12888892

5

Anti-metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum.

Ninomiya I, Terada I, Yoshizumi T, Takino T, Nagai N, Morita A, Fushida S, Nishimura G, Fujimura T, Ohta T, Miwa K. Ninomiya I, et al. Int J Cancer. 2004 Oct 20;112(1):135-42. doi: 10.1002/ijc.20360. Int J Cancer. 2004. PMID: 15305385

6

Trypsinogen expression and early detection for peritoneal dissemination in gastric cancer.

Fujimura T, Ohta T, Kitagawa H, Fushida S, Nishimura GI, Yonemura Y, Elnemr A, Miwa K, Nakanuma Y. Fujimura T, et al. Among authors: nishimura gi. J Surg Oncol. 1998 Oct;69(2):71-5. doi: 10.1002/(sici)1096-9098(199810)69:2<71::aid-jso5>3.0.co;2-r. J Surg Oncol. 1998. PMID: 9808508

7

Human pancreatic cancer cells disable function of Fas receptors at several levels in Fas signal transduction pathway.

Elnemr A, Ohta T, Yachie A, Kayahara M, Kitagawa H, Fujimura T, Ninomiya I, Fushida S, Nishimura GI, Shimizu K, Miwa K. Elnemr A, et al. Among authors: nishimura gi. Int J Oncol. 2001 Feb;18(2):311-6. doi: 10.3892/ijo.18.2.311. Int J Oncol. 2001. PMID: 11172597

8

PPARgamma ligand (thiazolidinedione) induces growth arrest and differentiation markers of human pancreatic cancer cells.

Elnemr A, Ohta T, Iwata K, Ninomia I, Fushida S, Nishimura G, Kitagawa H, Kayahara M, Yamamoto M, Terada T, Miwa K. Elnemr A, et al. Int J Oncol. 2000 Dec;17(6):1157-64. doi: 10.3892/ijo.17.6.1157. Int J Oncol. 2000. PMID: 11078801

9

Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.

Elnemr A, Ohta T, Yachie A, Kayahara M, Kitagawa H, Ninomiya I, Fushida S, Fujimura T, Nishimura G, Shimizu K, Miwa K. Elnemr A, et al. Int J Oncol. 2001 Jan;18(1):33-9. Int J Oncol. 2001. PMID: 11115536 Free article.

10

Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy.

Nishimura G, Terada I, Kobayashi T, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Kayahara M, Shimizu K, Ohta T, Miwa K. Nishimura G, et al. Oncol Rep. 2002 May-Jun;9(3):479-82. Oncol Rep. 2002. PMID: 11956613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters